Asare Obed/LinkedIn
Apr 28, 2026, 11:12
Asare Obed: Artificial Blood That Could Eliminate the Need for Blood Type Matching
Asare Obed, Digital Creator and AI Innovator, shared a post on LinkedIn:
“Scientists in Japan are working on groundbreaking artificial blood that could change medicine forever .
Unlike regular donated blood, this version can be used for anyone – no blood group matching needed .
Even better, it has a much longer shelf life, making it perfect for emergencies, disasters, and remote areas .
If successful, this innovation could solve global blood shortages and save millions of lives ”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD
-
Aug 11, 2026, 14:16Rayan Ahmed: Master Blood Films and Pathology Online
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India